Lotrel and Skin - clammy - a phase IV clinical study of FDA data

Summary:

Skin - clammy is reported as a side effect among people who take Lotrel (amlodipine besylate; benazepril hydrochloride), especially for people who are male, 60+ old, also take Zocor, and have Pain.

The phase IV clinical study analyzes which people have Skin - clammy when taking Lotrel. It is created by eHealthMe based on reports of 13,000 people who have side effects when taking Lotrel from the FDA, and is updated regularly.

What is Lotrel?

Lotrel has active ingredients of amlodipine besylate; benazepril hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 13,571 Lotrel users. Check the latest studies of Lotrel.

What is Skin - clammy?

Skin - clammy is found to be associated with 1,127 drugs and 1,709 conditions by eHealthMe. Check the latest studies of Skin - clammy.

On Jul, 14, 2026

13,000 people reported to have side effects when taking Lotrel.
Among them, 27 people (0.21%) have Skin - clammy.

Among these 27 people:

What is the gender of people who have Skin - clammy when taking Lotrel? *

female: 46.15 %
male: 53.85 %

What is the age of people who have Skin - clammy when taking Lotrel? *

What are other drugs people take besides Lotrel? *

What are other side effects people have besides Skin - clammy? *

Nausea (feeling of having an urge to vomit): 9 people, 33.33%
Stress And Anxiety: 8 people, 29.63%
Nausea And Vomiting: 7 people, 25.93%
Heart Rate Irregular: 6 people, 22.22%
Acute Kidney Failure: 5 people, 18.52%
Feeling Abnormal: 5 people, 18.52%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 5 people, 18.52%
Visual Impairment: 5 people, 18.52%
Pain: 5 people, 18.52%
Rashes (redness): 5 people, 18.52%

What are the existing conditions these people have? *

Pain: 3 people, 11.11%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 7.41%
Quit Smoking: 2 people, 7.41%
Diabetes: 2 people, 7.41%
Depression: 2 people, 7.41%
Weight Loss: 1 person, 3.70%
Toothaches (tooth pain): 1 person, 3.70%
Stress And Anxiety: 1 person, 3.70%
Panic Disorder: 1 person, 3.70%
Osteoporosis (bones weak and more likely to break): 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Lotrel and have Skin - clammy?

- Check whether Skin - clammy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lotrel:

Lotrel (13,571 reports)

Skin - clammy treatments and more:

Skin - clammy (19,745 reports)

How severe was Skin - clammy and when was it recovered:

Skin - clammy in Lotrel

Expand to all the drugs that have ingredients of amlodipine besylate; benazepril hydrochloride:

Skin - clammy and drugs with ingredients of amlodipine besylate; benazepril hydrochloride (31 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lotrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin - clammy:

Skin - clammy (1,127 drugs)

Browse all the conditions that are associated with Skin - clammy:

Skin - clammy (1,709 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate; benazepril hydrochloride (the active ingredients of Lotrel) and Lotrel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.